Peking University People's Hospital: Thrombocytopenia trials

The registry lists 39 Thrombocytopenia studies with Peking University People's Hospital as lead sponsor. 12 are open to participants now and 1 have results posted.

Phase 1 3Phase 2 34Phase 3 3No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid TumorsRecruitingNCT07586826Phase 2
• Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gastrointestinal Solid TumorsRecruitingNCT07586813Phase 2
• Longitudinal Cohort of Thrombosis and Hemostasis DiseasesRecruitingNCT06727669
• Prednisone Plus IVIg vs. Prednisone for ITP During PregnancyRecruitingNCT06577909Phase 2
• Efficacy and Safety of Avatrombopag in the Treatment of Thrombocytopenia After Haplo-HSCTRecruitingNCT06202625Phase 2/3
• Teriflunomide for Steroid-resistant/Relapse Immune ThrombocytopeniaRecruitingNCT06190145Phase 2
• The Combination of Teriflunomide and Danazol for Steroid-resistant/Relapse Immune ThrombocytopeniaRecruitingNCT06176911Phase 2
• Low-dose Baricitinib Plus High-dose Dexamethasone for Patients With Newly Diagnosed Immune ThrombocytopeniaRecruitingNCT05932524Phase 2
• Low-dose Baricitinib Plus Danazol for Steroid-resistant/Relapse Immune ThrombocytopeniaRecruitingNCT05852847Phase 2
• Combined Steroid and Cyclosporin as First-line Treatment in Adults With Primary Immune ThrombocytopeniaNot yet recruitingNCT05459649Phase 2
• Zanubrutinib and Eltrombopag as Second-line Treatment in Adults With Primary Immune ThrombocytopeniaNot yet recruitingNCT05369377Phase 2
• The Combination of Zanubrutinib and High-dose Dexamethasone as First-line Treatment in Adult Immune ThrombocytopeniaNot yet recruitingNCT05369364Phase 2
• A Study of Eltrombopag and Recombinant Human Thrombopoietin In Primary Immune ThrombocytopeniaStatus unknownNCT04214951Results posted
• IVIg Plus Low Dose rhTPO for ITP in PregnancyStatus unknownNCT05634824Phase 2
• The Combination of Terbutaline and Danazol as the Treatment of Corticosteroid-resistant/Relapse Immune ThrombocytopeniaStatus unknownNCT05494307Phase 2
• The Combination of Tacrolimus and Danazol as the Treatment of Steroid-resistant/Relapse Immune ThrombocytopeniaStatus unknownNCT05471050Phase 2
• Baricitinib for Steroid-resistant/Relapse Immune ThrombocytopeniaStatus unknownNCT05446831Phase 2
• The Combination of Sitagliptin and Danazol as the Treatment of Steroid-resistant/Relapse Immune ThrombocytopeniaStatus unknownNCT05353673Phase 2
• The Combination of Prednisone and Recombinant Human Thrombopoietin for Treatment of Immune Thrombocytopenia in PregnancyStatus unknownNCT05333744Phase 2
• Efficacy and Safety of Iguratimod in the Treatment of Steroid-resistant/Relapse Immune ThrombocytopeniaStatus unknownNCT05302024Phase 2
• The Combination of Iguratimod and Danazol as the Treatment of Steroid-resistant/Relapse Immune ThrombocytopeniaStatus unknownNCT05281068Phase 2
• A Study of Zanubrutinib in Patients With ITPCompletedNCT05279872Phase 2
• A Study of Orelabrutinib in Patients With ITPStatus unknownNCT05124028Phase 1/2
• Machine-learning Based Prediction Model in Primary Immune ThrombocytopeniaStatus unknownNCT05116423
• The Combination of Tacrolimus and High-dose Dexamethasone as First-line Treatment in Adult Immune ThrombocytopeniaStatus unknownNCT04747080Phase 2
• A Study of ATRA in the Treatment of ITPStatus unknownNCT04618328Phase 2
• Fixed Low-dose Eltrombopag and rhTPO for Immune Thrombocytopenia (FLOWER)Status unknownNCT04518878Phase 1
• Eltrombopag Plus rhTPO Versus Eltrombopag for ITP During the COVID-19 Pandemic (ELABORATE-19)Status unknownNCT04516837Phase 2
• The Combination of Terbutaline and Danazol as the Treatment of Steroid-resistant/Relapse Immune ThrombocytopeniaStatus unknownNCT04481282Phase 2
• The Combination of High-dose Dexamethasone and Acetylcysteine as the Treatment of Newly-diagnosed ITPStatus unknownNCT04368598Phase 2
• The Combination of ATRA and High-dose Dexamethasone as First-line Treatment in Adult Immune ThrombocytopeniaCompletedNCT04217148Phase 2
• The Combination of Atorvastatin, Acetylcysteine and Danazol as the Treatment of Steroid-resistant/Relapse Immune ThrombocytopeniaStatus unknownNCT03460808Phase 1/2
• Prolonged Isolated Thrombocytopenia After Allo-SCT : N-acetyl-L-cysteine (NAC) Versus Supportive TherapyTerminatedNCT03391856Phase 2/3
• The Combination of Low-dose Rituximab and ATRA as the Treatment of Steroid-resistant/Relapse Immune ThrombocytopeniaStatus unknownNCT03304288Phase 2
• Effect of NAC on the Hematopoietic Reconstitution After Haploidentical Hematopoietic Stem Cell TransplantationCompletedNCT03236220Phase 2
• Treatment of ITP With Rituximab and / or AccutaneStatus unknownNCT02757196Phase 2
• Thrombocytopenia in Gestational PeriodStatus unknownNCT02751593Phase 2/3
• Observation Study of Prednisone and Cyclosporine in Treatment of Thrombocytopenia in Hepatitis B CirrhosisStatus unknownNCT01987791
• The Combination of ATRA and Danazol as Second-line Treatment in Adult Immune ThrombocytopeniaCompletedNCT01667263Phase 2